EUVIMEDEUVIMED entdecken
Open Access

New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy

Luiz Anastácio Alves, André Bonavita, Kátia Quaresma, Elenilde Torres, Paulo Anastácio Furtado Pacheco, Vinícius Cotta-de-Almeida, Roberto Magalhães Saraiva

Cell Medicine · 2010

DOI: 10.3727/215517910x516646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Medicine, 2010. Verfasst von Luiz Anastácio Alves und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Comunicação Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz , Rio de Janeiro , Brazil. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute liver failure (ALF) has a poor prognosis and, despite intensive care support, reported average survival is only 10–40%. The most common causes responsible for ALF are viral hepatitis (mainly hepatitis A and B) and acetaminophen poisoning. Hepatic transplantation is the only appropriate treatment for patients with unlikely survival with supportive care alone. Survival rates after transplantation can be as high as 80–90% at the end of the first year. However, there is a shortage of donors and is not uncommon that no appropriate donor matches with the patient in time to avoid death. Therefore, new technologies are in constant development, including blood purification therapies as plasmapheresis, hemodiafiltration, and bioartificial liver support. However, they are still of limited efficacy or at an experimental level, and new strategies are welcome. Accordingly, cell transplantation has been developed to serve as a possible bridge to spontaneous recovery or liver transplantation. Xenotransplant of adult hepatocytes offers an interesting alternative. Moreover, the development of transgenic pigs with less immunogenic cells associated with new immunosuppressor strategies has allowed the development of this area. This article reviews some of the newly developed techniques, with focus on xenotransplant of adult hepatocytes, which might have clinical benefits as future treatment for ALF.

Schlagwörter

Stichwörter der Autor:innen

Acute liver failureCell therapySurvivalXenotransplantation

Autor:innen und Institutionen

  • Laboratório de Comunicação Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz , Rio de Janeiro , Brazil.
  • † Laboratório de Inovações em Terapias, Ensino e Bioprodutos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz , Rio de Janeiro , Brazil.
  • ‡ Instituto de Pesquisa Evandro Chagas (IPEC), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz , Rio de Janeiro , Brazil.

Zitieren

APA

Alves, L. A., Bonavita, A., Quaresma, K., Torres, E., Pacheco, P. A., Cotta-de-Almeida, V., & Saraiva, R. M. (2010). New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy. Cell Medicine. https://doi.org/10.3727/215517910x516646

Vancouver

Alves LA, Bonavita A, Quaresma K, Torres E, Pacheco PA, Cotta-de-Almeida V, et al. New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy. Cell Medicine. 2010. doi:10.3727/215517910x516646

BibTeX
@article{Alves2010,
  author = {Alves, Luiz Anastácio and Bonavita, André and Quaresma, Kátia and Torres, Elenilde and Pacheco, Paulo Anastácio Furtado and Cotta-de-Almeida, Vinícius and Saraiva, Roberto Magalhães},
  title = {New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy},
  journal = {Cell Medicine},
  year = {2010},
  doi = {10.3727/215517910x516646}
}
Kostenlos starten →